SGA Chinese university is investigating claims that a gene-editing trial led to the death of a six-year-old girl named 'Mei,' whose identity remains confidential. The girl received a spinal infusion of viruses intended to treat a rare genetic disorder affecting cognitive development. The treatment was part of research led by neuroscientist Zilong Qiu, whose subsequent study published in the journal Nature did not disclose the girl’s death. The university has formed a special committee to investigate the incident and emphasized its commitment to ethical research practices. Mei’s parents reportedly paid over $800,000 for the procedure but were not fully informed of the associated risks. This case adds to concerns surrounding China's rapid advancements in biotechnology, especially following the controversial 2018 gene-editing scandal involving He Jiankui.
Bias read (Center): The article presents the situation factually, citing multiple sources including the university's statement and external investigations. It does not exhibit overtly biased language or selective emphasis on one side. The framing remains neutral, focusing on the reported events and institutional review
Why factuality (95): The article cites a joint investigation by Science and Retraction Watch, which provides a credible source for the claim about the girl's death in a gene-editing trial. It mentions the university's official response and quotes statements from the institution, showing alignment with cross-source conse
Why objectivity (85): The article presents the information in a neutral tone, reporting the findings of an external investigation and quoting institutional responses. However, it uses emotionally charged language such as 'fresh blow to China's ambitions' which may imply a judgment on the significance of the event rather
